BRPI1006666A2 - "pharmaceutical composition and use of a pharmaceutical composition" - Google Patents

"pharmaceutical composition and use of a pharmaceutical composition"

Info

Publication number
BRPI1006666A2
BRPI1006666A2 BRPI1006666A BRPI1006666A BRPI1006666A2 BR PI1006666 A2 BRPI1006666 A2 BR PI1006666A2 BR PI1006666 A BRPI1006666 A BR PI1006666A BR PI1006666 A BRPI1006666 A BR PI1006666A BR PI1006666 A2 BRPI1006666 A2 BR PI1006666A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BRPI1006666A
Other languages
Portuguese (pt)
Inventor
Claire Mallard
Nathalie Willcox
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI1006666A2 publication Critical patent/BRPI1006666A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1006666A 2009-03-06 2010-03-05 "pharmaceutical composition and use of a pharmaceutical composition" BRPI1006666A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20251609P 2009-03-06 2009-03-06
FR0951416A FR2942716B1 (en) 2009-03-06 2009-03-06 METHOD FOR SOLUBILIZING ANTIFUNGAL AGENT AND COMPOSITIONS HAVING HIGH CONCENTRATION OF ANTIFUNGAL AGENT APPLICABLE ON THE NATIVE
PCT/EP2010/052817 WO2010100252A1 (en) 2009-03-06 2010-03-05 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail

Publications (1)

Publication Number Publication Date
BRPI1006666A2 true BRPI1006666A2 (en) 2016-04-19

Family

ID=41056884

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006666A BRPI1006666A2 (en) 2009-03-06 2010-03-05 "pharmaceutical composition and use of a pharmaceutical composition"

Country Status (11)

Country Link
EP (1) EP2403476A1 (en)
JP (1) JP2012519669A (en)
KR (1) KR20110121702A (en)
CN (1) CN102341092A (en)
AU (1) AU2010220266A1 (en)
BR (1) BRPI1006666A2 (en)
CA (1) CA2753638A1 (en)
FR (1) FR2942716B1 (en)
MX (1) MX2011009093A (en)
RU (1) RU2011140574A (en)
WO (1) WO2010100252A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
SI2672962T1 (en) * 2011-02-11 2015-06-30 Moberg Pharma Ab Novel antifungal composition
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
SG11201602596UA (en) 2013-10-03 2016-04-28 Dow Pharmaceutical Sciences Stabilized efinaconazole compositions
KR102612453B1 (en) 2013-11-22 2023-12-08 다우 파마슈티컬 사이언시즈, 인코포레이티드 Anti-infective methods, compositions, and devices
PT3209319T (en) * 2014-10-21 2021-09-24 Hexima Ltd A method of treatment
WO2026039635A1 (en) * 2024-08-14 2026-02-19 Foundling Pharma, Llc Improved compositions and methods for topical treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (en) * 1991-03-08 1993-06-11 Oreal USE OF HYDROPHILIC PENETRATION AGENTS IN DERMATOLOGICAL COMPOSITIONS FOR THE TREATMENT OF ONYCHOMYCOSES, AND CORRESPONDING COMPOSITIONS.
HU219480B (en) * 1991-05-23 2001-04-28 Novartis Ag. A method for the preparation of topical medicaments containing an allylamine derivative for the treatment of fungal circulatory diseases.
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug

Also Published As

Publication number Publication date
RU2011140574A (en) 2013-04-20
CN102341092A (en) 2012-02-01
FR2942716A1 (en) 2010-09-10
EP2403476A1 (en) 2012-01-11
FR2942716B1 (en) 2011-04-15
AU2010220266A1 (en) 2011-09-08
JP2012519669A (en) 2012-08-30
KR20110121702A (en) 2011-11-08
WO2010100252A1 (en) 2010-09-10
CA2753638A1 (en) 2010-09-10
MX2011009093A (en) 2011-09-27

Similar Documents

Publication Publication Date Title
BRPI1006666A2 (en) "pharmaceutical composition and use of a pharmaceutical composition"
BRPI1011876A2 (en) "stable pharmaceutical composition and methods of use"
BRPI0905680A2 (en) "pharmaceutical composition of a pharmaceutical composition"
BRPI0917315A2 (en) antibody, pharmaceutical composition, and use of a pharmaceutical composition
BRPI0821165A2 (en) Use of a composition
BRPI1014316A2 (en) composition and use of a composition
BRPI0813770A2 (en) COMPOSITION, AND, USE OF A COMPOSITION
BR112012002331A2 (en) antiviral composition, pharmaceutical composition and use of effective amount of pharmaceutical composition
BRPI1016219A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI1008793A2 (en) compound use of a compound and pharmaceutical composition
BR112012013148A2 (en) pharmaceutical formulation and use
BR112012015392A2 (en) "compound and cosmetic use of a compound"
BRPI0917001A2 (en) compound, pharmaceutical composition, and use of a compound or pharmaceutical composition
HRP20160579T1 (en) INDOLA COMPOUND AND ITS PHARMACEUTICAL USE
BRPI1005931A2 (en) compounding, use of a combination, kit product, use of a product and pharmaceutical composition
BRPI1013421A2 (en) topical parasticidal composition, and use of a
BRPI0918206A2 (en) animoester derivatives and medicinal composition of these
BRPI1006953A2 (en) pharmaceutical composition and use of a pharmaceutical composition
LT2966175T (en) PHARMACEUTICAL COMPOSITIONS OF CORTEXOLON-17-ALFA-PROPIONATE
BRPI1008039A2 (en) compound, mixture, pharmaceutical composition, and use of a compound, mixture or pharmaceutical composition
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
BRPI0914793A2 (en) Composition, and, use of a composition
BRPI0813017A2 (en) "NET FORMULATION AND USE OF A NET FORMULATION"
BRPI0906253A2 (en) Toothpaste composition and use of a composition
BR112012014028A2 (en) use of a composition

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES

B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]